Emilia Giugliano

Emilia Giugliano

UNVERIFIED PROFILE

Are you Emilia Giugliano?   Register this Author

Register author
Emilia Giugliano

Emilia Giugliano

Publications by authors named "Emilia Giugliano"

Are you Emilia Giugliano?   Register this Author

24Publications

365Reads

49Profile Views

FIP1L1-PDGFRα-positive hypereosinophilic syndrome in childhood: a case report and review of literature.

J Pediatr Hematol Oncol 2014 Jan;36(1):e28-30

*Pediatric Hematology and Oncology Unit, Oncology Department, A.R.N.A.S. Civico, Di Cristina and Benfratelli Hospitals ‡Hematology I, A.O. Villa Sofia-Cervello, Palermo †Molecular Biology Laboratory, Department of Clinical and Biologic Sciences, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPH.0b013e31827e6386DOI Listing
January 2014

Lenalidomide, melphalan, and prednisone association is an effective salvage therapy in relapsed plasma cell leukaemia.

J Oncol 2009 ;2009:867380

Department of Clinical and Biological Sciences, San Luigi Hospital, Regione Gonzole 10, Orbassano 10043, Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2009/867380DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2786165PMC
July 2011

Sustained molecular remissions are achievable with tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia and additional cytogenetic clonal evolution.

Cancer Genet Cytogenet 2010 Jun;199(2):139-42

Oncohematology Unit, Department of Clinical and Experimental Medicine, University of Perugia, S. Maria Hospital, Via Tristano di Joannuccio 1, 05100 Terni, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cancergencyto.2010.02.008DOI Listing
June 2010

Frequency and distribution of trisomy 11 in multiple myeloma patients: relation with overexpression of CCND1 and t(11;14).

Cancer Genet Cytogenet 2007 Feb;173(1):51-6

Department of Clinical and Biological Sciences, University of Turin and St. Luigi Hospital, Regione Gonzole 10, 10043 Orbassano, Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cancergencyto.2006.09.017DOI Listing
February 2007

Rational approaches to the design of therapeutics targeting molecular markers: the case of chronic myelogenous leukemia.

Ann N Y Acad Sci 2004 Dec;1028:423-31

Dept. of Clinical and Biological Sciences of the University of Turin, San Luigi Hospital, Gonzole 10, 10043, Orbassano-Torino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1196/annals.1322.050DOI Listing
December 2004

Two new translocations involving the 11q23 region map outside the MLL locus in myeloid leukemias.

Haematologica 2002 Oct;87(10):1014-20

Medicina Interna II, Dipartimento di Scienze Cliniche e Biologiche, Osp. S. Luigi Gonzaga, Orbassano, Italy.

View Article

Download full-text PDF

Source
October 2002

From genes to therapy: the case of Philadelphia chromosome-positive leukemias.

Ann N Y Acad Sci 2002 Jun;963:306-12

Department of Clinical and Biological Sciences, University of Turin, Hospital S. Luigi Gonzaga, 10043, Orbassano-Torino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1749-6632.2002.tb04122.xDOI Listing
June 2002